Sebastian Mayer

3.1k total citations
111 papers, 2.0k citations indexed

About

Sebastian Mayer is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Sebastian Mayer has authored 111 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Hematology, 44 papers in Oncology and 25 papers in Molecular Biology. Recurrent topics in Sebastian Mayer's work include Hematopoietic Stem Cell Transplantation (42 papers), Acute Myeloid Leukemia Research (15 papers) and Polyomavirus and related diseases (15 papers). Sebastian Mayer is often cited by papers focused on Hematopoietic Stem Cell Transplantation (42 papers), Acute Myeloid Leukemia Research (15 papers) and Polyomavirus and related diseases (15 papers). Sebastian Mayer collaborates with scholars based in United States, Germany and United Kingdom. Sebastian Mayer's co-authors include Andreas C. Joerger, Alan R. Fersht, Elmar Stickeler, G. Gitsch, Thalia Erbes, Marc Hirschfeld, Usama Gergis, Koen van Besien, Tsiporah B. Shore and Markus Jaeger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Sebastian Mayer

99 papers receiving 2.0k citations

Peers

Sebastian Mayer

HEMAT

ONCOL

IMMUN

Torsten Keßler Germany

Michael Loughnan Australia

Pamela Kearns United Kingdom

Christopher C. Porter United States

Yubin Kang United States

Francisco Ayala Spain

Carsten Grüllich Germany

Edgar Jost Germany

Karen Seiter United States

Andrew L. Gilman United States

Torsten Keßler Germany

Sebastian Mayer

950 ×1.1

529 ×0.8

HEMAT

685 ×1.1

ONCOL

341 ×1.2

197 ×0.9

IMMUN

Citations per year, relative to Sebastian Mayer Sebastian Mayer (= 1×) peers Torsten Keßler

Countries citing papers authored by Sebastian Mayer

Since Specialization

Citations

This map shows the geographic impact of Sebastian Mayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebastian Mayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebastian Mayer more than expected).

Fields of papers citing papers by Sebastian Mayer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sebastian Mayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebastian Mayer. The network helps show where Sebastian Mayer may publish in the future.

Co-authorship network of co-authors of Sebastian Mayer

This figure shows the co-authorship network connecting the top 25 collaborators of Sebastian Mayer. A scholar is included among the top collaborators of Sebastian Mayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sebastian Mayer. Sebastian Mayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fingrut, Warren, et al.. (2025). Availability of Suitable Domestic Cord Blood Grafts for Adult Allograft Recipients With Hematologic Malignancies. Transplantation and Cellular Therapy. 32(1). 92.e1–92.e8.

Ge, Isabell, Benjamin Schmidt, Markus Jäger, et al.. (2025). Long non‑coding RNA signatures in breast cancer: Properties as biomarkers?. Experimental and Therapeutic Medicine. 29(3). 54–54.

Gribbin, Caitlin, Anna Alperovich, Barbara Ma, et al.. (2025). Real-world assessment of prophylactic anakinra on neurotoxicity after CD19 CAR T-cell therapy in R/R B-cell lymphoma: An inverse probability of treatment weighting analysis. Blood. 146(Supplement 1). 712–712.

Khaled, Samer K., Jaap Jan Boelens, Mitchell S. Cairo, et al.. (2021). Narsoplimab (OMS721), a Masp-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HSCT-TMA). Transplantation and Cellular Therapy. 27(3). S24–S26. 2 indexed citations

Soave, Rosemary, Zhengming Chen, Tsiporah B. Shore, et al.. (2021). Adenovirus viremia after in vivo T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes. Leukemia & lymphoma. 63(2). 435–442. 2 indexed citations

Hirschfeld, Marc, Isabell Ge, Sebastian Mayer, et al.. (2020). Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in�vitro. Molecular Medicine Reports. 22(5). 4048–4060. 9 indexed citations

Cushing, Melissa M., Usama Gergis, Jingmei Hsu, et al.. (2020). Cord blood transplants supported by unrelated donor CD34+ progenitor cells. Bone Marrow Transplantation. 55(12). 2298–2307. 5 indexed citations

Gergis, Usama, Tsiporah B. Shore, Sebastian Mayer, et al.. (2018). Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary Outcomes. Biology of Blood and Marrow Transplantation. 25(3). 466–473. 1 indexed citations

Hsu, Jingmei, Marshall J. Glesby, Tsiporah B. Shore, et al.. (2018). CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational Study. Blood. 132(Supplement 1). 2184–2184.

10.

Choe, Hannah, Usama Gergis, Tsiporah B. Shore, et al.. (2017). Kidney Dysfunction Post-Allogeneic Transplant: High Incidence of TMA and Kidney GvHD. Blood. 130. 5500–5500. 1 indexed citations

11.

Cushing, Melissa M., Ljiljana V. Vasović, Kathleen Kane, et al.. (2017). Safe and Effective Implementation of a Red Blood Cell (RBC) Transfusion Hemoglobin (Hb) Threshold of 7 g/Dl on an Inpatient Stem Cell Transplant Unit: A Single Institution Experience. Blood. 130. 1131–1131. 1 indexed citations

12.

Shore, Tsiporah B., Usama Gergis, Jingmei Hsu, et al.. (2017). Novel Risk Factors for Epstein-Barr Virus (EBV) Reactivation and Post-Transplant Lymphoproliferative Disorder (PTLD) after Allogeneic Hematopoietic Stem Cell Transplant. Blood. 130. 1949–1949. 3 indexed citations

13.

Hsu, Jingmei, Andrew Artz, Sebastian Mayer, et al.. (2017). Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation. 24(2). 359–365. 15 indexed citations

14.

Eismann, Julia, Marc Hirschfeld, Thalia Erbes, et al.. (2017). Hypoxia- and acidosis-driven aberrations of secreted microRNAs in endometrial cancer in vitro. Oncology Reports. 38(2). 993–1004. 17 indexed citations

15.

Erbes, Thalia, Elmar Stickeler, Gerta Rücker, et al.. (2016). BMI and Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Study and Meta-Analysis. Clinical Breast Cancer. 16(4). e119–e132. 24 indexed citations

16.

Shah, Shreya, et al.. (2015). Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan–Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 22(3). 456–461. 9 indexed citations

17.

Hausen, Axel zur, Sebastian Mayer, Marc Hirschfeld, et al.. (2013). Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications. BMC Cancer. 13(1). 271–271. 41 indexed citations

18.

Ahmad, Kami, Ari Melnick, Denis Bouchard, et al.. (2003). Mechanism of SMRT Corepressor Recruitment by the BCL6 BTB Domain. Molecular Cell. 12(6). 1551–1564. 214 indexed citations

19.

Mayer, Sebastian, Georgios Karanikas, Margarida Rodrigues, & H. Sinzinger. (2000). Influence of drugs on myocardial iodine-123 metaiodobenzylguanidine uptake in rabbit myocardium. European Journal of Nuclear Medicine and Molecular Imaging. 27(3). 340–345. 10 indexed citations

20.

Quoix, E., et al.. (1978). [Hereditary antithrombin III deficiency causing recurrent thrombo-embolic problems (author's transl)].. PubMed. 7(12). 999–1002. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact